MPE at ASH 2024: key research and expert insights on myelomaAL amyloidosis, CAR-T, Conferences, MPE, MyelomaDecember 16, 2024
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, latest, MPE, Myeloma, NewsNovember 29, 2024
Myeloma and AL amyloidosis ASH 2024 previewAccess, AL amyloidosis, CAR-T, MPE, MyelomaNovember 29, 2024
Official launch of EuroBloodNet, the European Reference Network on rare haematological diseasesAL amyloidosis, MyelomaMarch 21, 2017
Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosisAccess, AL amyloidosisJune 6, 2019
ASH 2023 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, MPE, MyelomaDecember 15, 2023
MPE launches a report focused on the impact of AL amyloidosis in quality of lifeAL amyloidosis, MPENovember 21, 2023
